| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Aurobindo Pharma Limited (NSE: AUROPHARMA)
AUROPHARMA Technical Analysis
4
| As on 25th Apr 2024 AUROPHARMA SHARE Price closed @ 1103.40 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 924.55 & Buy for SHORT-TERM with Stoploss of 1056.52 we also expect STOCK to react on Following IMPORTANT LEVELS. |
AUROPHARMASHARE Price
| Open | 1081.05 | Change | Price | % |
| High | 1106.95 | 1 Day | 19.35 | 1.78 |
| Low | 1079.10 | 1 Week | -11.10 | -1.00 |
| Close | 1103.40 | 1 Month | 83.55 | 8.19 |
| Volume | 1642872 | 1 Year | 502.90 | 83.75 |
| 52 Week High 879.25 | 52 Week Low 404.20 | ||||
| AUROPHARMA CURRENT MONTH FUTURE | |||
| Close | 1105.10 | ||
| Contracts Traded | 3116300 | ||
| Open Intrest | 246400 | ||
| Change In O.I | -85.96 % | ||
| Lot Size | 1100 | ||
| AUROPHARMA CURRENT MONTH OPTION | |
| Most Active Call | 1100.00 |
| Most Active put | 1000.00 |
| Highest O.I Buildup Call | 1140.00 |
| Highest O.I Buildup Put | 960.00 |
| Expiry Date | 2024-04-25 |
| AUROPHARMA ALL MONTHS OPTIONS | |||
| For All AUROPHARMA Options Click Here | |||
NSE INDIA Most Active Stocks
| IDEA | 13.90 | 6.11% |
| YESBANK | 25.95 | 1.96% |
| KOTAKBANK | 1642.45 | -10.87% |
| SOUTHBANK | 30.40 | 4.47% |
| SAIL | 164.95 | 0.18% |
| PNB | 135.90 | 2.18% |
| TATASTEEL | 167.70 | 1.30% |
| AXISBANK | 1127.00 | 6.00% |
| IRFC | 150.25 | 0.84% |
| IOB | 66.90 | 5.77% |
NSE INDIA Top Gainers Stocks
| ROML | 75.65 | 19.98% |
| POWERINDIA | 9329.50 | 13.60% |
| GPTINFRA | 211.80 | 12.51% |
| NEOGEN | 1557.75 | 12.25% |
| PNC | 65.00 | 11.02% |
| PNC | 65.00 | 11.02% |
| PNC | 65.00 | 11.02% |
| PNC | 65.00 | 11.02% |
| MOIL | 430.70 | 10.88% |
| GODFRYPHLP | 3449.70 | 10.17% |
NSE INDIA Top Losers Stocks
| AUROPHARMA Daily Charts |
AUROPHARMA Intraday Charts |
Whats New @ Bazaartrend |
AUROPHARMA Free Analysis |
|
|
AUROPHARMA Important Levels Intraday
| RESISTANCE | 1157.07 |
| RESISTANCE | 1139.86 |
| RESISTANCE | 1129.22 |
| RESISTANCE | 1118.58 |
| SUPPORT | 1088.22 |
| SUPPORT | 1077.58 |
| SUPPORT | 1066.94 |
| SUPPORT | 1049.73 |
AUROPHARMA Target April 2024
| 4th UP Target | 1447.64 |
| 3rd UP Target | 1312.55 |
| 2nd UP Target | 1229.04 |
| 1st UP Target | 1145.54 |
| 1st DOWN Target | 907.26 |
| 2nd DOWN Target | 823.76 |
| 3rd DOWN Target | 740.25 |
| 4th DOWN Target | 605.16 |
AUROPHARMA Weekly Target
| 4th UP Target | 1217.99 |
| 3rd UP Target | 1176.00 |
| 2nd UP Target | 1150.04 |
| 1st UP Target | 1124.08 |
| 1st DOWN Target | 1050.02 |
| 2nd DOWN Target | 1024.06 |
| 3rd DOWN Target | 998.10 |
| 4th DOWN Target | 956.11 |
AUROPHARMA Target2024
| 4th UP Target | 2438.1 |
| 3rd UP Target | 2003.83 |
| 2nd UP Target | 1735.4 |
| 1st UP Target | 1466.97 |
| 1st DOWN Target | 701.03 |
| 2nd DOWN Target | 432.6 |
| 3rd DOWN Target | 164.17 |
| 4th DOWN Target | -270.1 |
Aurobindo Pharma Limited ( NSE INDIA Symbol : AUROPHARMA )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
AUROPHARMA Synopsis Technicals View
| 50 Day EMA |
Close is Above EMA 50 (Short Term) |
Bullish | |
| 100 Day EMA | Close is Above EMA 100 (Mid Term) | Bullish | |
| 200 Day EMA | Close is Above EMA 200 (Long Term) | Bullish | |
| MACD (12 26 9) | MACD Line is Less Then SIGNAL Line | Bearish | |
| RSI (14) | RSI is 32.45 | Sideways | |
| MFI (14) | MFI is 53.29 | Sideways | |
| CCI (20) | CCI is Below -100 | Over Sold | |
| WILLIAM %R (14) | William %R is Below -80 | Over Sold | |
| ADX (14) | ADX is Above 20 & +DI is Below -DI | Down Trend | |
| PSAR | Stoploss For Long Buy | 485.16 | |
| 10 Day Avg Volume | Traded 70.74 % More then 10 Day Average Volume | ||
AUROPHARMA Other Details
| Segment | EQ | |
| Market Capital | 415430770688.00 | |
| Sector | Healthcare | |
| Industry | Drug Manufacturers-Specialty & Generic | |
| Offical website | > | |
AUROPHARMA Address
 |
||
AUROPHARMA Latest News
AUROPHARMA Business Profile
Aurobindo Pharma Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients, generic pharmaceuticals, and related services in India. The company primarily offers oral solids, injectables, over the counter drugs, and dietary supplements, as well as active pharmaceutical ingredients and finished dosage forms for cardiovascular, central nervous system, gastroenterology, anti-allergies, anti-diabetics, anti-retroviral, antibiotics, dermatology, respiratory, and oncology. It is also involved in the development of a product pipeline in biosimilar and vaccine segments; and custom research and manufacturing activities for the bio-tech and pharmaceutical community. In addition, the company develops and manufactures peptides, as well as biocatalysts for use in the pharmaceutical and chemical industries. Further, it is developing biosimilar, inhalers, transdermal patches, vaccines, topicals, and depot injections. The company also exports its products. It serves multinational companies. The company has an agreement with COVAXX to develop and commercialize COVID-19 Vaccine for India and UNICEF. Aurobindo Pharma Limited was incorporated in 1986 and is headquartered in Hyderabad, India. Address: Galaxy, Plot No. 1, Hyderabad, India, 500032
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service